Virtanen I - Search Results

1

Transcription factors zeb1, twist and snai1 in breast carcinoma.

Soini Y, Tuhkanen H, Sironen R, Virtanen I, Kataja V, Auvinen P, Mannermaa A, Kosma VM. Soini Y, et al. Among authors: virtanen i. BMC Cancer. 2011 Feb 16;11:73. doi: 10.1186/1471-2407-11-73. BMC Cancer. 2011. PMID: 21324165 Free PMC article.

2

Nuclear expression of Snail1 in borderline and malignant epithelial ovarian tumours is associated with tumour progression.

Tuhkanen H, Soini Y, Kosma VM, Anttila M, Sironen R, Hämäläinen K, Kukkonen L, Virtanen I, Mannermaa A. Tuhkanen H, et al. Among authors: virtanen i. BMC Cancer. 2009 Aug 20;9:289. doi: 10.1186/1471-2407-9-289. BMC Cancer. 2009. PMID: 19695091 Free PMC article.

3

Transcription factor snail1 expression and poor survival in pharyngeal squamous cell carcinoma.

Jouppila-Mättö A, Tuhkanen H, Soini Y, Pukkila M, Närkiö-Mäkelä M, Sironen R, Virtanen I, Mannermaa A, Kosma VM. Jouppila-Mättö A, et al. Among authors: virtanen i. Histol Histopathol. 2011 Apr;26(4):443-9. doi: 10.14670/HH-26.443. Histol Histopathol. 2011. PMID: 21360437

4

Tenascin in salivary gland tumours.

Soini Y, Pääkkö P, Virtanen I, Lehto VP. Soini Y, et al. Among authors: virtanen i. Virchows Arch A Pathol Anat Histopathol. 1992;421(3):217-22. doi: 10.1007/BF01611178. Virchows Arch A Pathol Anat Histopathol. 1992. PMID: 1384222

5

Tenascin in reactive lymph nodes and in malignant lymphomas.

Soini Y, Alavaikko M, Lehto VP, Virtanen I. Soini Y, et al. Among authors: virtanen i. Pathol Res Pract. 1992 Dec;188(8):1078-82. doi: 10.1016/S0344-0338(11)81254-9. Pathol Res Pract. 1992. PMID: 1284450

6

Tenascin immunoreactivity as a prognostic marker in usual interstitial pneumonia.

Kaarteenaho-Wiik R, Tani T, Sormunen R, Soini Y, Virtanen I, Pääkkö P. Kaarteenaho-Wiik R, et al. Among authors: virtanen i. Am J Respir Crit Care Med. 1996 Aug;154(2 Pt 1):511-8. doi: 10.1164/ajrccm.154.2.8756830. Am J Respir Crit Care Med. 1996. PMID: 8756830

7

Tenascin immunoreactivity in lung tumors.

Soini Y, Pääkkö P, Nuorva K, Kamel D, Linnala A, Virtanen I, Lehto VP. Soini Y, et al. Among authors: virtanen i. Am J Clin Pathol. 1993 Aug;100(2):145-50. doi: 10.1093/ajcp/100.2.145. Am J Clin Pathol. 1993. PMID: 7689293

8

Tenascin immunoreactivity in normal and pathological bone marrow.

Soini Y, Kamel D, Apaja-Sarkkinen M, Virtanen I, Lehto VP. Soini Y, et al. Among authors: virtanen i. J Clin Pathol. 1993 Mar;46(3):218-21. doi: 10.1136/jcp.46.3.218. J Clin Pathol. 1993. PMID: 7681854 Free PMC article.

9

Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin-C and other factors.

Jahkola T, Toivonen T, von Smitten K, Virtanen I, Wasenius VM, Blomqvist C. Jahkola T, et al. Among authors: virtanen i. Br J Cancer. 1999 Apr;80(1-2):167-74. doi: 10.1038/sj.bjc.6690336. Br J Cancer. 1999. PMID: 10389993 Free PMC article.

10

Matrix metalloproteinase-2 and matrix metalloproteinase-9 codistribute with transcription factors RUNX1/AML1 and ETV5/ERM at the invasive front of endometrial and ovarian carcinoma.

Planagumà J, Liljeström M, Alameda F, Bützow R, Virtanen I, Reventós J, Hukkanen M. Planagumà J, et al. Among authors: virtanen i. Hum Pathol. 2011 Jan;42(1):57-67. doi: 10.1016/j.humpath.2010.01.025. Epub 2010 Oct 20. Hum Pathol. 2011. PMID: 20970160

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

585 results

Search Page

Filters